- Home
- PCRX vs BBN Comparison
PCRX vs BBN Comparison
Compare PCRX & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- BBN
- Stock Information
- Founded
- PCRX 2006
- BBN 1983
- Country
- PCRX United States
- BBN United States
- Employees
- PCRX N/A
- BBN N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- BBN Finance Companies
- Sector
- PCRX Health Care
- BBN Finance
- Exchange
- PCRX Nasdaq
- BBN Nasdaq
- Market Cap
- PCRX 1.2B
- BBN 1.0B
- IPO Year
- PCRX 2011
- BBN N/A
- Fundamental
- Price
- PCRX $25.12
- BBN $16.00
- Analyst Decision
- PCRX Buy
- BBN
- Analyst Count
- PCRX 9
- BBN 0
- Target Price
- PCRX $29.89
- BBN N/A
- AVG Volume (30 Days)
- PCRX 782.0K
- BBN 231.8K
- Earning Date
- PCRX 05-08-2025
- BBN 01-01-0001
- Dividend Yield
- PCRX N/A
- BBN 6.90%
- EPS Growth
- PCRX N/A
- BBN N/A
- EPS
- PCRX N/A
- BBN N/A
- Revenue
- PCRX $702,772,000.00
- BBN N/A
- Revenue This Year
- PCRX $9.48
- BBN N/A
- Revenue Next Year
- PCRX $11.31
- BBN N/A
- P/E Ratio
- PCRX N/A
- BBN N/A
- Revenue Growth
- PCRX 3.08
- BBN N/A
- 52 Week Low
- PCRX $11.16
- BBN $14.33
- 52 Week High
- PCRX $31.67
- BBN $18.36
- Technical
- Relative Strength Index (RSI)
- PCRX 48.10
- BBN 45.87
- Support Level
- PCRX $25.08
- BBN $15.94
- Resistance Level
- PCRX $27.34
- BBN $16.17
- Average True Range (ATR)
- PCRX 1.16
- BBN 0.16
- MACD
- PCRX -0.18
- BBN 0.02
- Stochastic Oscillator
- PCRX 48.85
- BBN 47.26
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.